1505484-82-1

  • Product Name:Nemorexant
  • Molecular Formula:C23H23ClN6O2
  • Purity:99%
  • Molecular Weight:450.928
Inquiry

Product Details:

CasNo: 1505484-82-1

Molecular Formula: C23H23ClN6O2

Factory Supply High Purity Nemorexant 1505484-82-1,Factory Sells 1505484-82-1 Best Price

  • Molecular Formula:C23H23ClN6O2
  • Molecular Weight:450.928
  • Boiling Point:747.6±70.0 °C(Predicted) 
  • Density:1.42±0.1 g/cm3(Predicted) 

Nemorexant(Cas 1505484-82-1) Usage

Description

Nemeroxant is a selective dual orexin receptor antagonist (DORA) that is used to treat insomnia. It is also known by the name daridorexant.
Uses

Daridorexant, formerly known as nemorexant, is a selective dual orexin receptor antagonist used to treat insomnia. Insomnia is characterized by difficulties with sleep onset and/or sleep maintenance and impairment of daytime functioning.

1505484-82-1 Relevant articles

CYP3A4 Catalyzes the Rearrangement of the Dual Orexin Receptor Antagonist Daridorexant to 4‐Hydroxypiperidinol Metabolites

A Treiber,H Aissaoui,S Delahaye,S Glutz,J Grimont,C Müller,S Seeland,V Siefken,C Boss

, ChemMedChem, 2023

With human liver microsomes, daridorexant underwent hydroxylation at the methyl group of the benzimidazole moiety, oxidative O‐demethylation of the anisole to the corresponding phenol, and hydroxylation to a 4‐hydroxy piperidinol derivative.

The Quest for the Best Dual Orexin Receptor Antagonist (Daridorexant) for the Treatment of Insomnia Disorders

Boss, Christoph,Gatfield, John,Brotschi, Christine,Heidmann, Bibia,Sifferlen, Thierry,von Raumer, Markus,Schmidt, Gunther,Williams, Jodi T.,Treiber, Alexander,Roch, Catherine

, p. 2286 - 2305 (2020)

Since its discovery in 1998, the orexin ...

1505484-82-1 Process route

5-methoxy-2-(2H-1,2,3-triazol-2-yl)benzoic acid
1293284-55-5

5-methoxy-2-(2H-1,2,3-triazol-2-yl)benzoic acid

C<sub>13</sub>H<sub>16</sub>ClN<sub>3</sub>*ClH

C13H16ClN3*ClH

(S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone
1505484-82-1

(S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone

Conditions
Conditions Yield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In dichloromethane; at 20 ℃; for 16h;
63%
N-(tert-butoxycarbonyl)-2-methyl-L-proline
103336-06-7

N-(tert-butoxycarbonyl)-2-methyl-L-proline

(S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone
1505484-82-1

(S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone

Conditions
Conditions Yield
Multi-step reaction with 3 steps
1.1: N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate / dichloromethane / 16 h / 20 °C
1.2: 1 h / 100 °C
2.1: hydrogenchloride / 1,4-dioxane / 1.5 h / 20 °C
3.1: N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate / dichloromethane / 16 h / 20 °C
With hydrogenchloride; N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In 1,4-dioxane; dichloromethane;
 

1505484-82-1 Upstream products

  • 103336-06-7
    103336-06-7

    N-(tert-butoxycarbonyl)-2-methyl-L-proline

  • 673487-36-0
    673487-36-0

    4-chloro-3-methylbenzene-1,2-diamine

  • 1293284-55-5
    1293284-55-5

    5-methoxy-2-(2H-1,2,3-triazol-2-yl)benzoic acid

  • 54413-93-3
    54413-93-3

    2-iodo-5-methoxybenzoic acid

Relevant Products